Markntel Advisors’ report, Organ-on-Chip Research Report: Trend, Business Growth, Size, Future Scope, Segmentation, Dynamics, and Forecast to 2030, offers a comprehensive guide for the growing industry. The expert team of analysts dedicated significant effort to gathering and evaluating the latest market data, resulting in a detailed and up-to-date report that offers valuable insights for individuals who rely on data-driven decisions, including business owners and analysts. The research report on the Organ-on-Chip presents well-researched facts and figures pertinent to the industry, whether the goal is to explore new markets, launch a new product, or maintain a competitive advantage.
Organ-on-Chip Market Research Report & Market Summary:
The Global Organ-on-Chip Market size was valued at around USD 126 million in 2024 and is projected to reach USD 950 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 40% during the forecast period (2025-30). Various factors are attributed to the growth of the market. The increasing demand for alternatives to animal testing in drug discovery and toxicological studies is boosting the market growth. Advancements in microfluidic technology coupled with an increasing focus on personalized medicine and precision healthcare are likely to fuel the market demand. Moreover, the rise in research funding, collaborations between academia & industry, and regulatory support for Organ-on-a-chip technologies can propel the market growth over the forecast period. Also, government funding, support, and initiatives in various regions globally are further boosting the market growth.
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/organ-on-chip-market.html
Organ-on-Chip Market Dynamics:
Key Driver-
Growing Demand for Alternatives to Animal Testing in Drug Discovery – The worldwide market for organ-on-chip technology is driven by the growing need for alternatives to animal testing in drug discovery. To enhance safety & efficacy evaluations and lessen the ethical issues surrounding animal testing regulatory organizations like the FDA and EMA promote the use of sophisticated in-vitro models. The FDA Modernization Act 2.0. passed by the USA government in the year 2022, will greatly decrease the use of animal drug testing by promoting the use of substitute techniques like organ-on-chips. Precise simulation of human organ function through systems such as the liver and lung on chips offers increased predictive accuracy of drug toxicity and metabolism studies. For instance; Emulate’s liver on a chip has been widely utilized to predict hepatotoxicity in candidates for drugs reducing dependence on animal models. This shows how Organ-On-Chip technology is changing the scenario of preclinical testing to provide ethical and cost-effective solutions for the pharmaceutical industry with alternatives to animal testing.
Organ-on-Chip Market Segmentation Analysis:
According to MarkNtel study the market is segmented into the following categories:
By Model Type
- Organ-Based Model- Market Size & Forecast 2020-2030, USD Million
- Disease-Based Model- Market Size & Forecast 2020-2030, USD Million
By Material
- Polydimethylsiloxane (PDMS)- Market Size & Forecast 2020-2030, USD Million
- Polymer- Market Size & Forecast 2020-2030, USD Million
- Glass- Market Size & Forecast 2020-2030, USD Million
By Solution
- Products- Market Size & Forecast 2020-2030, USD Million
- Instruments- Market Size & Forecast 2020-2030, USD Million
- Consumables & Accessories – Market Size & Forecast 2020-2030, USD Million
- Software- Market Size & Forecast 2020-2030, USD Million
- Services- Market Size & Forecast 2020-2030, USD Million
- Custom Services- Market Size & Forecast 2020-2030, USD Million
- Standard Services- Market Size & Forecast 2020-2030, USD Million
By Organ Type
- Liver-Market Size & Forecast 2020-2030, USD Million
- Intestine-Market Size & Forecast 2020-2030, USD Million
- Kidney-Market Size & Forecast 2020-2030, USD Million
- Lung-Market Size & Forecast 2020-2030, USD Million
- Heart-Market Size & Forecast 2020-2030, USD Million
- Other organs
Based on organ type, the Liver segment leads the global market. It holds approx. 30% of the total market value. Their extensive use in liver disease studies, toxicity testing, and drug metabolism contributes to the high percentage share.
By Application
- Toxicology Research-Market Size & Forecast 2020-2030, USD Million
- Drug Discovery-Market Size & Forecast 2020-2030, USD Million
- Physiological Model Development-Market Size & Forecast 2020-2030, USD Million
- Stem cell Research-Market Size & Forecast 2020-2030, USD Million
- Tissue regeneration and regenerative Medicines-Market Size & Forecast 2020-2030, USD Million
- Others
By End User
- Pharmaceutical and Biotechnology Companies-Market Size & Forecast 2020-2030, USD Million
- Cosmetics Industry-Market Size & Forecast 2020-2030, USD Million
- Academic and Research Institutes-Market Size & Forecast 2020-2030, USD Million
- Others
Based on end users, pharmaceutical and biotechnology lead the market. It holds approx. 73% market share. This growth is because of their considerable use of OoC systems for drug discovery, testing of toxicity, and the modeling of diseases.
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific.
Out of them, North America dominates the Global Organ-on-Chip Market. It holds approx. 52% market share. The region is supported by robust investments in biomedical research, superior infrastructure, and the presence of major industry players.
As indicated in the latest market research report published by Markntel Advisors, “Organ-on-Chip Research Report: Forecast (2025-2030)”, this report offers a detailed analysis of the industry, featuring insights into the Organ-on-Chip industry. It encompasses competitor and geographical analyses, as well as recent advancements in the market.
Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/organ-on-chip-market.html
Top Companies Operating in the Organ-on-Chip Market:
- Altis Biosystems
- AlveoliX AG
- Axosim
- Bi/ond Solutions B.V
- Cherry Biotech
- CN-Bio
- Emulate, Inc.
- Hesperos, Inc.
- Insphero
- MesoBioTech
- Mimetas B.V.
- Nortis Inc.
- React4Life
- TARA Biosystems (Valo Health)
- TissUse GmbH
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*
Other Report:
- https://tach-amit.blogspot.com/2025/02/angola-new-commercial-vehicle-market.html
- https://tach-amit.blogspot.com/2025/02/africa-air-conditioner-industry.html
- https://tach-amit.blogspot.com/2025/01/drone-parachutes-market-insight.html
- https://tach-amit.blogspot.com/2025/01/digital-camera-market-insight-industry.html
- https://tach-amit.blogspot.com/2025/01/5g-in-automotive-market-analysis-size.html
Key Report Highlights:
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Frequently Asked Questions (FAQs)-
- What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
- What are the trends influencing the current scenario of the market?
- What leading factors would propel and impede the industry across the geography?
- How has the industry been evolving in terms of geography & Organ-on-Chip Market adoption?
- How has the competition been shaping up across the geography?
- Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call + +1 628 895 8081, +91 120 4278433
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
